The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage.
about
The role of osteoprotegerin in arthritisRANK/RANKL/OPG system in the intervertebral disc.Chondroclasts are mature osteoclasts which are capable of cartilage matrix resorption.Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK.Role of RANKL and RANK in bone loss and arthritis.Bone destruction in arthritis.Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis.Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritisReceptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysisErosive arthritis.RANK, RANKL and osteoprotegerin in arthritic bone loss.Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research.RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritisMechanisms of Disease: the link between RANKL and arthritic bone disease.Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Cells of the synovium in rheumatoid arthritis. Chondrocytes.Regulation of RANKL by biomechanical loading in fibrochondrocytes of meniscusCartilage homeostasis in health and rheumatic diseases.Increased receptor activator of nuclear factor κβ ligand/osteoprotegerin ratio exacerbates cartilage destruction in osteoarthritis in vitroModulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis.6-Mer hyaluronan oligosaccharides increase IL-18 and IL-33 production in mouse synovial fibroblasts subjected to collagen-induced arthritis.Receptor activator of nuclear factor kappa B ligand serum and synovial fluid level. A comparative study between rheumatoid arthritis and osteoarthritis.The cell biology and role of resorptive cells in diseases: A review.IL-1beta suppresses the formation of osteoclasts by increasing OPG production via an autocrine mechanism involving celecoxib-related prostaglandins in chondrocytes.Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes.Post-embryonic remodelling of neurocranial elements: a comparative study of normal versus abnormal eye migration in a flatfish, the Atlantic halibut.Influence of Tumor Necrosis Factor α, Parathyroid Hormone, and Vitamin D3 on Modulation of the RANKL2 Isoform: A Pilot Study.Generalized Degenerative Joint Disease in Osteoprotegerin (Opg) Null Mutant Mice.Differential effects of p38MAP kinase inhibitors on the expression of inflammation-associated genes in primary, interleukin-1beta-stimulated human chondrocytes.Inflammatory cells and bone loss in rheumatoid arthritis.The proinflammatory cytokines IL-1beta and TNF-alpha induce the expression of Synoviolin, an E3 ubiquitin ligase, in mouse synovial fibroblasts via the Erk1/2-ETS1 pathway.Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening.Influence of osteoarthritis grade on molecular signature of human cartilage.The expression of RANKL and OPG in the various grades of osteoarthritic cartilage.
P2860
Q24797889-7D086FAD-67B5-4BEC-9C87-6159A5662518Q33759501-8E76C2B6-C81E-4662-9644-8EF45E4FC3C8Q34287203-C804AC11-20C2-4C10-8222-E5B5CFD1BB83Q34667359-AAC7F1AE-034D-494B-B374-86B0D72CCA82Q34963016-70017D0E-1B99-4BBA-BCBF-3F8A1EB5F149Q34963176-A7DD926B-CBA1-4BDB-AEA4-F52215509C4FQ35789185-A74D6AAA-B04E-4FB9-82D7-040B227F3F6CQ35840709-18D0AD57-2D7C-44E1-A4D6-549D96002B4BQ35843398-2890DA05-A115-4DF6-BEFF-F49FFE8059C4Q35901078-042DF3DF-E7D4-47CD-951B-840EF090F0E1Q36078073-C0BE3447-530C-4097-B24B-12633B7797AAQ36134548-CCA31783-4E95-4B62-AA4A-3197A4D466D6Q36246148-34C0BAA7-EBAE-4983-981D-EA35A305C35CQ36577375-36F210C6-FC1B-437F-8306-06EC87A12305Q36860987-3D301F41-2B60-4B89-8689-4F100EE4BC6CQ37000837-9E4BFE0D-9C00-4733-BBFA-C8BB9C390B84Q37108817-EB2FC97A-E288-48A6-998D-AED515E40192Q37270714-0B12B42A-1CA1-4B89-8ED7-009CAD0DF0C0Q37288057-23545CEC-41BD-4D49-AF94-8BDBCE1489D4Q37596614-17DE7517-6FA7-4ED6-990C-9788CD4C72F9Q38328255-759B7C1F-B85A-4680-9C60-8AFC071252A9Q38991582-940A38C4-151A-4228-AEA3-702F5858356CQ39281517-7006F89F-3158-4DDE-8606-BB0219BA642CQ39315218-12CA0205-A3A1-4427-8913-002F572F749BQ39335782-FCBC0716-58B2-4788-B191-A9447CD02AF6Q40309701-1FB5CC00-AD08-4A6B-9D06-CB946CF222C1Q40840942-BCD9882A-5BEB-412D-821C-9925006C1148Q40896014-BC8E1639-EC8D-47C6-BBFA-571B6210E535Q42429559-2444D239-C998-4A5B-AABA-DFA104D3E20FQ42549439-5D2A8D92-AE4A-439B-B495-003E5E8FEF62Q42962015-8A7CA71F-5DE7-41FB-83A1-E5235D92C74BQ51728955-EADEA5F7-9FE7-4D19-B1B1-2BBB4F9EA6E4Q53357943-C73FC181-18B4-4EC5-84A1-304C5CE5314CQ54391375-E0C51191-E412-43F7-A19C-B75AB57D8996
P2860
The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
The osteoprotegerin/receptor a ...... aB ligand system in cartilage.
@en
The osteoprotegerin/receptor a ...... aB ligand system in cartilage.
@nl
type
label
The osteoprotegerin/receptor a ...... aB ligand system in cartilage.
@en
The osteoprotegerin/receptor a ...... aB ligand system in cartilage.
@nl
prefLabel
The osteoprotegerin/receptor a ...... aB ligand system in cartilage.
@en
The osteoprotegerin/receptor a ...... aB ligand system in cartilage.
@nl
P2093
P2860
P1476
The osteoprotegerin/receptor a ...... aB ligand system in cartilage.
@en
P2093
Brinson DC
Creighton-Achermann L
Shikhman A
Valbracht J
P2860
P304
P356
10.1002/1529-0131(200112)44:12<2768::AID-ART464>3.0.CO;2-I
P577
2001-12-01T00:00:00Z